BRCA2 and Hereditary breast and ovarian cancer syndrome: Out of five remaining carriers with diffuse GC not meeting HDGC criteria, one met Hereditary Breast and Ovarian Cancer (HBOC) syndrome testing criteria and had a BRCA2 variant.